All imaging was performed under general anesthesia as already described above. OCT (SOCT Copernicus; OPTOPOL Technology S.A., Zawiercie, Poland; wavelength 840 nm, axial resolution 6 µm, and transversal resolution of 12–18 µm) was performed bilaterally on all rabbit eyes. To visualize the iridocorneal angle, including the inflow area of the implanted microstent in case of operated eyes, the animals were positioned upright in front of the device and the eye was opened by a lid speculum for OCT examination. OCT was carried out 2 weeks as well as 4 weeks after surgery and then subsequently every 4 weeks until the end of the study to evaluate the correct position of the implants and to detect implant dislocations at an early stage. MRI of the microstents was performed with an ultrahigh field small animal MR scanner (7 Tesla, BioSpec 70/30 USR, gradient: BGA 20S, gradient strength: 200 mT/m, Bruker BioSpin MRI GmbH, Bremen, Germany) equipped with a 152-mm (inner diameter) volume resonator in transmit-only mode, and a 2 × 2 receive-only surface coil in receive mode (both Bruker). Animal eyes were imaged in coronal and sagittal slice orientation using a T2-weighted TurboRARE sequence (TE/TR = 35/4000 ms, rare factor = 8, averages = 1, field of view = 20 × 18.7 mm, matrix = 133 × 125, slice thickness = 1.0 mm, in-plane resolution = 150 µm × 150 µm). For the MRI measurement, the breathing rate of the rabbits was monitored (Model 1030, SA Instruments Inc., Stony Brook, NY) during the scans. To prevent eyes from drying Vidisic eye gel (Bausch & Lomb Inc., Rochester, NY) was used and the lids were carefully shut. The surface coil was placed proximal to the closed eye. The first MRI was conducted 4 weeks after surgery and subsequently every 4 weeks until the end of the study.
Partial Protocol Preview
This section provides a glimpse into the protocol. The remaining content is hidden due to licensing restrictions, but the full text is available at the following link:
Access Free Full Text.
Siewert S., Kischkel S., Brietzke A., Kinzel L., Lindner T., Hinze U., Chichkov B., Schmidt W., Stiehm M., Grabow N., Guthoff R.F., Schmitz K.P, & Stahnke T. (2023). Development of a Novel Valve-Controlled Drug-Elutable Microstent for Microinvasive Glaucoma Surgery: In Vitro and Preclinical In Vivo Studies. Translational Vision Science & Technology, 12(3), 4.
Time (2 weeks, 4 weeks, and every 4 weeks thereafter)
dependent variables
Position of implanted microstents
Dislocations of implanted microstents
control variables
General anesthesia
Positioning of animals (upright in front of OCT device, with eye opened by lid speculum)
Breathing rate monitoring during MRI scans
Prevention of eye drying (Vidisic eye gel, closed lids) during MRI scans
controls
Positive control: None mentioned
Negative control: None mentioned
Annotations
Based on most similar protocols
Etiam vel ipsum. Morbi facilisis vestibulum nisl. Praesent cursus laoreet felis. Integer adipiscing pretium orci. Nulla facilisi. Quisque posuere bibendum purus. Nulla quam mauris, cursus eget, convallis ac, molestie non, enim. Aliquam congue. Quisque sagittis nonummy sapien. Proin molestie sem vitae urna. Maecenas lorem.
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to
get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required